secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2026-08-21T20:05:14+00:00
Accession:  0001193125-26-361079
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo annual meeting: both director nominees elected, all four proposals approved
--------------------------------------------------------------------------------

- Zs. Harsanyi re-elected director: 216,997 for, 17,454 withheld; Barbara Lopez Kunz: 211,050 for, 23,401 withheld.
- Ratification of Baker Tilly US LLP as 2026 auditor: 606,661 for, 28,847 against, 1,370 abstain.
- Advisory vote on 2025 executive compensation approved: 165,615 for, 24,031 against, 44,805 abstain.
- Fourth Amended and Restated 2018 Stock Incentive Plan approved: 166,484 for, 64,248 against, 3,719 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000119312526361079/0001193125-26-361079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000119312526361079/apvo-20260821.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-361079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer